Population Science Studies
Project Title |
Principal Investigator |
Institution |
Sample Size |
Diagnosis Years |
Project Start & End Years |
Risk Factors for Ductal Carcinoma In Situ |
Brody, Julia |
Silent Spring Institute |
n=224 patients from the Cape Cod Breast Cancer and Environment Study |
1992-1998 |
2003-2006 |
Breast Carcinoma In-Situ: Mammographic Risk Factors |
Claus, Elizabeth |
Yale University |
n=875 with DCIS; n=123 with LCIS who are CT residents; n=999 controls |
1994-1998 |
2004-2008 |
Cost-Effectiveness -- Treatments -- Ductal Carcinoma In Situ |
Dick, Andrew / Griggs, Jennifer |
University of Rochester |
SEER-Medicare |
|
2002-2005 |
Microsatellite Markers of DCIS Prognosis |
Gabrielson, Edward |
Johns Hopkins Universtiy |
|
|
1999-2002 |
Etiology of Early Breast Malignancy |
Greenberg, Robert |
Dartmouth College |
n=412 women with DCIS from NH and VT cancer registries
n=412 women with invasive breast cancer |
|
1996-2002 |
DCIS--Mammographic features and prognosis |
Habel, Laurel |
Kaiser Foundation Research Institute |
n=1200 women with DCIS from the Northern California Kaiser Permanente Medical Care Program |
1990-1997 |
1999-2005 |
Mammographic density and breast cancer after diagnosis of DCIS |
Habel, Laurel |
Kaiser Foundation Research Institute |
n=814 patients from the National Surgical Adjuvant Breast and Bowel Program Clinical Trial
|
|
1999-2002 |
Clinical/Pathologic Predictors for Recurrence after DCIS |
Habel, Laurel |
Kaiser Foundation Research Institute |
n=3700 patients (n=490 with recurrence) from the CRN, Kaiser Permanente Northern California, Kaiser Permanente Souther California, Harvard Pilgrim Health Care |
1990-2001 |
2003-2007 |
Surgical Treatment for Early State Breast Cancer |
Katz, Steven |
University of Michigan, Ann Arbor |
n=1880 patients from SEER catchment areas
|
|
2001-2005 |
Predictors of Recurrence in Women with DCIS |
Kerlikowse, Karla |
University of California, San Francisco |
n=1,744 from Northern California SEER
n=457 from UCSF for the Breast Oncology Program database
n=1,3 10 women from the NSABPB-17 and NSABPB-24 trials. |
1983-1996 |
2003-2007 |
Treatment Decisions Comparing DCIS/Invasive BC patients |
Lantz, Paula |
University of Michigan, Ann Arbor |
n=200 patients with DCIS or invasive breast cancer reported to Detroit SEER Registry
|
|
1997-1999 |
A Video DVD Program to Assist with Informed Consent |
Love, Neil |
NL Communications, Inc |
n=3000 |
|
2004-2005 |
Case-Control Study of Carcinoma In Situ |
Millikan, Bob |
University of North Carolina Chapel Hill |
n=400 cases of DCIS or LCIS from the Carolina Breast Cancer Study and frequency-matched controls |
1995-2000 |
Not listed |
Risk Factors and Biomarkers for In Situ Breast Cancer |
Newcomb, Polly and Titus-Ernstoff, Linda |
Fred Hutchinson Cancer Research Center and Dartmouth College |
n=1575 cases of DCIS or LCIS from WI, MA, and NH state cancer registries
n=2205 population-based controls |
|
1996-2002 |
Cost Effectiveness Analysis of Breast Cancer Screening |
Plevritis, Sylvia |
Stanford University |
|
|
1999-2003 |
Breast Cancer Trend Analysis Using Stochastic Stimulati |
Plevritis, Sylvia |
Stanford University |
|
|
2000-2005 |
Clinical Studies
Project Title |
Principal Investigator |
Institution |
Sample Size |
Project Start & End Years |
A her-2/neu Pulsed DC1 Vaccine for Patients with DCIS |
Czerniecki, Brian |
University of Pennsylvania |
Practice-based recruitment |
2003-2007 |
Cytogenic Screening of Mammary Epithelial Cells |
Haddad, Bassem |
Georgetown University |
n=50 controls; n=50 women with atypical ductal hyperplasia; n=50 women with DCIS; n=50 women with stage 1 breast cancer |
2000-2003 |
Primary Hormonal Therapy for DCIS of the Breast |
Hwang, Shelley |
University of California, San Francisco |
n=40 postmenopausal patients with DCIS |
2004-2009 |
MRI for Staging DCIS and Assessing Response to Treatment |
Hylton, Nola |
University of California, San Francisco |
Patients with biopsy-proven DCIS |
2006-2011 |
PNI and Decision Making in Women Diagnosed with DCIS |
Janusek, Linda |
Loyola University of Chicago |
n=122 women with newly diagnosed DCIS |
2004-2008 |
Quality of Life Over Time: DCIS vs Early Breast Cancer |
Jeffe, Donna |
Washington University |
Women with normal or benign mammograms will be identified surgeons |
2003-2008 |
Synergy of Inverse Scatter & Vibro-Acoustics |
Johnson, Steven |
Techniscan, Inc |
Patients selected from a population with positive mammograms for micro calcifications |
2004-2006 |
Fast Spectroscopic MR Imaging of Breast Cancer |
Karczmar, Gregory |
University of Chicago |
n=300 women scheduled for routine MRI exams prior to biopsy
|
1999-2008 |
Immune Dysregulation by Psychosocial Distress |
Mathews, Herbert |
Loyola University of Chicago |
Women diagnosed with DCIS |
2005-2008 |
Interactive Decision Making Program for DCIS |
Mort, Elizabeth |
Massachusetts General Hospital |
|
1995-1999 |
New Approaches to Sampling and Analyzing Contrast Media |
Newstead, Gillian |
University of Chicago |
n=150 patients per year |
2005-2008 |
Cyclin E Expression in Human Cancer |
Porter, Peggy |
Fred Hutchinson Cancer Research Center |
n=225 tissue samples from women with DCIS
n=913 tissue samples from women with invasive breast cancer |
2000-2004 |
Detecting Breast Cancer Protein Signatures in Body Fluid |
Trock, Bruce |
Johns Hopkins University |
fresh tumor tissue that contains invasive, in-situ and abnormal components; body fluids fromm women with normal breasts, DCIS, and stage 1 cancer |
1999-2005 |
EGFR Pathway Modulation in DCIS of the Breast |
Truica, Christina |
Vanderbilt University |
Patients with DCIS |
2003-2005 |
Psychosocial outcomes/health behaviors: women with DCIS |
Winer, Eric |
Dana Farber Cancer Institute |
n=450 women from academic and community health care institutions |
Not listed |
Basic Science Studies
Project Title |
Principal Investigator |
Institution |
Sample |
Project Start & End Years |
Molecular Classification and Prognostic Profiling of Ductal Carcinoma in Situ |
Allred, Craig |
Baylor College of Medicine |
n=25 fresh-frozen DCIS samples and matched cases of normal breast and invasive breast cancer |
2003-2007 |
Role of Cancer Stem Cells in Malignant Progression of Ductal Carcinoma in Situ |
Behbod, Fariba |
|
Premalignant cell lines and subtypes of human DCIS |
2007-2009 |
Role of Stat3 in Breast Cancer Tumorigenesis |
Bromberg, Jacqueline |
Sloan-Kettering Institute for Cancer Research |
Cell lines, transgenic animals, human tissue |
2001-2006 |
Characterization of the Chromosome 17q23 Amplicon |
Couch, Fergus |
Mayo Clinic College of Medicine |
Breast tumors and cell lines |
2002-2008 |
VPF/VEGF in Breast Cancer Angiogenesis |
Dvorak, Harold |
Beth Israel Deaconess Medical Center |
Human breast lesions and carcinomas from mice |
1995-2000 |
Expression of Aryl Hydrocarbon Receptor in Breast Tumors |
Elton, Sakina |
Meharry Medical College |
Human breast cancer cell lines |
Not listed |
Integrated Biomarkers to Characterize Breast Cancer Risk |
Esserman, Laura |
University of California San Francisco |
|
2004-2009 |
A Hypersensitive ERa Mutant in Breast Cancer Progression |
Fuqua, Suzanne |
Baylor College of Medicine |
Clinical breast tumor bank |
1996-2008 |
Molecular Variants of Estrogen and Progesterone Receptors in Breast Cancer |
Fuqua, Suzanne |
Baylor College of Medicine |
|
Not listed |
Mechanisms Regulating Reversal of Malignancy |
Furth, Priscilla |
Georgetown University |
Mouse model |
2006-2010 |
Progression and Regression of Mammary Preneoplasia |
Furth, Priscilla |
Georgetown University |
Mouse model |
2004-2009 |
Somatic Genetic Changes in Early Breast Cancer |
Geradts, Joseph |
Roswell Park Cancer Institute |
n=35 low grade DCIS samples, n=35 low grade DCIS samples associated with an invasive component |
2005-2008 |
Immunologic Studies in Mouse and Human Breast Cancer |
Girardi, Anthony |
Coriell Institute for Medical Research |
|
|
Secreted Proteins as Breast Cancer Prevention Markers |
Gould, Michael |
University of Wisconsin, Madison |
Rat model |
2003-2008 |
Neu Activation and the Etiology of Mammary Cancer |
Gould, Michael |
University of Wisconsin, Madison |
Cell lines |
1993-1999 |
Characterizing a Breast Cancer Modifier Locus that Associated with Human Risk |
Gould, Michael |
University of Wisconsin, Madison |
Rat models and human studies |
2006-2011 |
Modulation of Carcinogenesis by Monoterpenoids |
Gould, Michael |
University of Wisconsin, Madison |
Cell lines |
1984-2000 |
Chemoprevention in a Mouse Model of DCIS |
Gregg, Jeffrey |
University of California, Davis |
Mouse model |
2007-2009 |
CPG Island Methylator Phenotypes in Breast Cancer |
Huang, Tim H-M |
Ohio State Universtiy |
Human breast tumors |
2007-2012 |
Wwox as a Critical Signal Mediator in Breast Can |
Huebner, Kay |
Ohio State Universtiy |
Breast cancer cell line and tissue |
2006-2009 |
Cancer Prevention by Selenium-Enriched Allium Vegetables |
Ip, Clement |
Roswell Park Cancer Institute |
|
1980-2005 |
Molecular biomarkers of selenium chemoprevention |
Ip, Clement |
Roswell Park Cancer Institute |
Human breast cell lines, mouse and rat models |
2002-2008 |
Pilot -- AH Receptor in Human Breast Tumors |
Jensen, Roy |
Vanderbilt University |
Human breast carcinoma cell lines |
Not listed |
Characterization of HIN1 Putative Tumor Supressor |
Krop, Ian |
Dana Farber Cancer Institute |
Normal and DCIS mammary epithelial cells |
2002-2003 |
DNA Repair and Breast Cancer |
Latimer, Jean |
Magee Women's Health Corporation |
Tumor and non-tumor breast epithelium |
1997-2005 |
Genomic Instability and Etiology of Extrogen Oncogenesis |
Li, Jonathan |
University of Kansas Medical Center |
|
2003-2008 |
Application of Genomic Microarrays to Breast Cancer |
Lucito, Robert |
Cold Spring Harbor Laboratory |
|
2002-2007 |
Differential Protein Expression by MALDI TOF MS |
Lubman, David |
University of Michigan, Ann Arbor |
Human breast epithelial cell line |
2001-2004 |
MCF10DCIS.com As a Preclinical Chemopreventive Screen |
Miller, Fred |
Wayne State University |
Human breast epithelial cell line |
2002-2005 |
Proteomics of Progression in MCF10 Xenograft Model |
Miller, Fred |
Wayne State University |
Human breast cell line |
2002-2007 |
VP Peptides and Receptors in Diagnosis of Breast Cancer |
North, William |
Dartmouth College |
|
2005-2007 |
GRSA Proteins in the Diagnosis of Breast Cancer |
North, William |
Dartmouth College |
|
2001-2004 |
Molecular Genetic Markers of Pre-Malignant and Pre-Invasive Breast Disease |
O'Connell, Peter |
University of Texas Health Sciences Center |
Breast cancer specimens |
Not listed |
Translational Research in Breast Cancer |
Osborne, Kent |
Baylor College of Medicine |
|
1992-2007 |
Human Aldo Keto Reductases and Steroid Hormone Ac |
Penning, Trevor |
University of Pennsylvania |
Human breast cell lines and biopsy samples |
2001-2007 |
Breast stem cell analysis in random periareolar fine needle aspirates from high r |
Petroff, Brian |
University of Kansas Medical Center |
Samples of breast tissue from women at high risk for breast cancer |
2007-2009 |
Molecular Markers in DCIS |
Polyak, Kornelia |
Dana Farber Cancer Institute |
Benign, in situ, invasive breast tissue |
Not listed |
HIN-1, A Novel Putative Breast Tumor Supressor Gene |
Polyak, Kornelia and Porter, Dale |
Dana Farber Cancer Institute |
Normal and cancerous breast tissue, and mouse model |
2002-2008 |
Identification of Receptor for Tumor Suppressor HIN-1 |
Porter, Dale |
Dana Farber Cancer Institute |
Mammary epithelial cells |
2002-2004 |
Epithelial-Stromal Cell Interactions in Breast Cancer |
Polyak, Kornelia |
Dana Farber Cancer Institute |
Human xenograft models in mice and human breast tumors |
2006-2011 |
Immune Response to Breast Ductal Carcinoma In Situ |
Pruitt, Scott |
Duke University |
Guinea pig-to-Lewis rat model |
1992-2000 |
Genetic Signatures of Preinvasive Breast Disease |
Rosenberg, Carol |
Boston Medical Center |
Breast cancer-containing tissue |
2007-2008 |
Molecular Basis of Breast Cell Transformation |
Russo, Jose |
Fox Chase Cancer Center |
Human breast epithelial cells |
1995-2000 |
Centrosome Hypertrophy in Human Breast Tumors |
Salisbury, Jeffrey |
Mayo Clinic College of Medicine |
Normal breast epithelial and breast tumor cell lines, and human breast tissue |
1998-2001 |
Cripto in the Pathogeneis of Breast and Colon Cancer |
Salomon, David |
National Cancer Institute |
|
2006 |
Prevention of Breast Cancer with Sphingolipids |
Schmelz, Eva |
Wayne State University |
Cell models for early and late stages of breast cancer |
2003-2006 |
Molecular Markers for High Risk of Breast Cancer |
Smith, Helene |
University of California, San Francisco |
Cases of pure DCIS and DCIS associated with invasive cancers, and nonmalignant epithelium samples |
Not listed |
Technology for Global and Quantitative Proteome Analysis |
Smith, Richard |
Battelle Pacific Northwest Laboratories |
Breast tissue |
2001-2003 |
Mechanisms of Mammary Gland Carcinogenesis of Heterocycl |
Snyderwine, Elizabeth |
National Cancer Institute |
Rat model, human breast tissue |
2005 |
Molecular Alterations in Premalignant and In-Situ Breast |
Steeg, Patricia |
|
Cell lines |
Not listed |
Molecular Markers for Breast Cancer |
Sukumar, Saraswati |
Johns Hopkins University |
Large panel of breast tumors |
2000-2005 |
Selenium and Apoptosis in Cancer Prevention |
Thompson, Henry |
AMC Cancer Researh Center |
Rat model |
Not listed |
Iron and Mammary Carcinogenesis |
Thompson, Henry |
AMC Cancer Researh Center |
Rat model |
1996-2000 |
Risk Marker/Chemoprevention Target Identification |
Tlsty, Thea |
University of California, San Francisco |
Human mammary epithelial cells and human breast tissue |
2003-2007 |
14-3-3zeta in ErbB2 Mediated Mammary Carcinogenesis |
Yu, Dihua |
University of Texas MD Anderson Cancer Center |
Mammary epithelial cells |
2005-2010 |
14-3-3zeta in Early Stages of Breast Cancer Progression |
Yu, Dihua |
University of Texas MD Anderson Cancer Center |
Mammary epithelial cells and tissues from patients |
2004-2009 |
Gene Amplification in Breast Cancer |
Wigler, Michael |
Sloan-Kettering Institute for Cancer Research |
|
Not listed |